STAT

‘We, as a society, should be outraged’: a conversation about public health

Leading figures in health and medicine sound an alarm about growing disparities between rich and poor, lack of scientific literacy in the public, and more.

STAT’s flagship newsletter has been getting readers ahead of the day’s health news for two years — and to celebrate, we convened a group of experts in the Boston area to talk about the most pressing issues in health and medicine.

Our panel: Dr. Sandro Galea, dean of the Boston University School of Public Health; Kate Walsh, president and CEO of Boston Medical Center; Mary Tolikas, engineer and operations director of the Wyss Institute at Harvard; and Dr. Harris Berman, dean of Tufts University School of Medicine.

The following excerpts have been lightly edited and grouped

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks